446287-05-4 Usage
Uses
Used in Organic Synthesis:
5-Bromo-2-methoxy-1,3-thiazole is used as a building block for the synthesis of various organic compounds. Its unique structure, which includes a bromine atom and a methoxy group, makes it a valuable intermediate in the creation of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 5-Bromo-2-methoxy-1,3-thiazole is utilized as an intermediate in the development of new drugs. Its presence in the molecular structure can contribute to the pharmacological properties of the final drug product, enhancing its therapeutic potential.
Used in Agrochemical Industry:
5-Bromo-2-methoxy-1,3-thiazole has been studied for its potential applications in the agrochemical sector. Its use may involve the development of new pesticides or other agrochemicals that can improve crop protection and yield.
Safety Considerations:
It is important to handle 5-Bromo-2-methoxy-1,3-thiazole with care, as it may pose hazards if not properly managed. Adherence to safety guidelines is essential to ensure the safe use of 5-Bromo-2-methoxy-1,3-thiazole in research and industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 446287-05-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,4,6,2,8 and 7 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 446287-05:
(8*4)+(7*4)+(6*6)+(5*2)+(4*8)+(3*7)+(2*0)+(1*5)=164
164 % 10 = 4
So 446287-05-4 is a valid CAS Registry Number.
InChI:InChI=1/C4H4BrNOS/c1-7-4-6-2-3(5)8-4/h2H,1H3
446287-05-4Relevant academic research and scientific papers
PYRAZOLOPYRIMIDINE DERIVATIVE AND USE THEREOF AS PI3K INHIBITOR
-
Paragraph 0088-0090, (2021/06/03)
The present invention discloses a series of pyrazolopyrimidine derivatives and use thereof in preparing a medicament for treating a disease related to PI3K, and in particular, discloses a derivative compound of formula (I), a tautomer thereof or a pharmaceutically acceptable composition thereof.
Dihydroisoquinoline compound
-
Paragraph 0479-0484, (2020/07/24)
The invention provides a dihydroisoquinoline compound or a pharmaceutically acceptable salt, ester, isomer, solvate, hydrate, prodrug or isotope marker thereof. The compound has a structure shown as ageneral formula I. The compound has extremely strong activity of inhibiting hepatitis B surface antigen, also has extremely strong activity of inhibiting hepatitis B DNA, has relatively high bioavailability, can play a drug effect at a relatively low dosage, and reduces the potential toxicity of the compound.
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
-
Page 119, (2008/06/13)
This invention provides compounds having drug and bio-affecting properties, their pharmaceutical compositions and method of use. In particular, the invention is concerned with azaindoleoxoacetyl piperazine derivatives. These compounds possess unique antiviral activity, whether used alone or in combination with other antivirals, antiinfectives, immunomodulators or HIV entry inhibitors. More particularly, the present invention relates to the treatment of HIV and AIDS.
